Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biopharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:ABC
- CUSIP: N/A
- Web: www.abcam.com/
- Market Cap: £2 billion
- Outstanding Shares: 202,199,000
- 50 Day Moving Avg: GBX 964.59
- 200 Day Moving Avg: GBX 863.28
- 52 Week Range: GBX 628 - GBX 998.50
Sales & Book Value:
- Trailing P/E Ratio: 49.72
- P/E Growth: 0.00
- Annual Revenue: £195.56 million
- Price / Sales: 10.23
- Book Value: GBX 1.44 per share
- Price / Book: 6.87
- EBIDTA: £67.65 million
- Net Margins: 19.33%
- Return on Equity: 14.31%
- Return on Assets: 11.57%
- Average Volume: 585,029 shs.
Frequently Asked Questions for Abcam Plc (LON:ABC)
What is Abcam Plc's stock symbol?
Abcam Plc trades on the London Stock Exchange (LON) under the ticker symbol "ABC."
How often does Abcam Plc pay dividends? What is the dividend yield for Abcam Plc?
Abcam Plc announced a dividend on Monday, March 6th. Shareholders of record on Thursday, March 16th will be paid a dividend of GBX 2.83 per share on Thursday, April 13th. This represents a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, March 16th. The official announcement can be viewed at this link. View Abcam Plc's Dividend History.
When will Abcam Plc make its next earnings announcement?
Where is Abcam Plc's stock going? Where will Abcam Plc's stock price be in 2017?
5 brokerages have issued twelve-month price targets for Abcam Plc's shares. Their predictions range from GBX 680 to GBX 912. On average, they anticipate Abcam Plc's stock price to reach GBX 819.20 in the next year. View Analyst Ratings for Abcam Plc.
Who are some of Abcam Plc's key competitors?
Some companies that are related to Abcam Plc include Anika Therapeutics (ANIK), Myovant Sciences Ltd (MYOV), Syros Pharmaceuticals (SYRS), ChemoCentryx (CCXI), Sinovac Biotech (SVA), Syndax Pharmaceuticals (SNDX), Fortress Biotech (FBIO), Kamada (KMDA), Mereo BioPharma Group PLC (MPH), Kadmon Holdings (KDMN), Peregrine Pharmaceuticals (PPHM), MediWound (MDWD), VIVUS (VVUS), Cardiome Pharma Corporation (CRME), Strongbridge Biopharma PLC (SBBP), Vericel Corporation (VCEL), Alimera Sciences (ALIM) and KalVista Pharmaceuticals (KALV).
Who are Abcam Plc's key executives?
Abcam Plc's management team includes the folowing people:
- Alan Thomas Hirzel, Chief Executive Officer, Executive Director
- Gavin Hilary James Wood, Chief Financial Officer, Executive Director
- Suzanne Elaine Smith, Chief Legal Officer, Company Secretary
- Jonathan Simon Milner Ph.D., Deputy Chairman of the Board
- Murray Edwin Hennessy, Non-Executive Chairman of the Board
- Mara Glickman Aspinall, Non-Executive Director
- Susan Elizabeth Harris, Non-Executive Director
- Louise A. V. C. Patten, Senior Independent Non-Executive Director
How do I buy Abcam Plc stock?
Shares of Abcam Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abcam Plc's stock price today?
MarketBeat Community Rating for Abcam Plc (LON ABC)MarketBeat's community ratings are surveys of what our community members think about Abcam Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Abcam Plc stock can currently be purchased for approximately GBX 989.50.
Consensus Ratings for Abcam Plc (LON:ABC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 4 Hold Ratings|
|Consensus Rating:||Hold (Score: 1.80)|
|Consensus Price Target: ||GBX 819.20|
Analysts' Ratings History for Abcam Plc (LON:ABC)
(Data available from 6/25/2015 forward)
|5/2/2017||Stifel Nicolaus||Reiterated Rating||Hold||GBX 890|
|4/20/2017||Panmure Gordon||Reiterated Rating||Sell||GBX 680|
|4/4/2017||Numis Securities Ltd||Upgrade||Add||GBX 912|
|3/27/2017||J P Morgan Chase & Co||Boost Price Target||Neutral||GBX 678 -> GBX 864|
|3/17/2017||Peel Hunt||Reiterated Rating||Hold||GBX 750|
|4/4/2016||Royal Bank Of Canada||Initiated Coverage||Sector Performer||GBX 610|
|11/2/2015||Canaccord Genuity||Upgrade||Hold||GBX 432|
|7/23/2015||FinnCap||Reiterated Rating||Under Review|
Earnings History for Abcam Plc (LON:ABC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Abcam Plc (LON:ABC)
Current Year EPS Consensus Estimate: $60.67 EPS
Dividend History by Quarter for Abcam Plc (LON ABC)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Abcam Plc (LON:ABC)Insider Trades by Quarter for Abcam Plc (LON:ABC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/5/2017||Mara G Aspinall||Insider||Buy||2,700||GBX 979||£26,433|
|3/22/2017||Alan Thomas Hirzel||Insider||Buy||6,000||GBX 809||£48,540|
|3/20/2017||Alan Thomas Hirzel||Insider||Buy||6,000||GBX 839||£50,340|
|12/8/2016||Mara G Aspinall||Insider||Buy||298||GBX 786||£2,342.28|
|12/7/2016||Alan Thomas Hirzel||Insider||Buy||227||GBX 792||£1,797.84|
|12/2/2016||P. Warwick||Insider||Sell||30,000||GBX 808||£242,400|
|9/30/2016||Louise Patten||Insider||Buy||12,378||GBX 836||£103,480.08|
|9/19/2016||Milner,Jonathan Simon||Insider||Sell||20,361||GBX 820||£166,960.20|
|11/11/2015||Hirzel,Alan Thomas||Insider||Buy||3,335||GBX 580||£19,343|
|9/18/2015||Hirzel,Alan Thomas||Insider||Buy||4,000||GBX 615||£24,600|
|3/26/2015||Jonathan Simon Milner||Insider||Sell||2,480,000||GBX 465||£11,532,000|
Headline Trends for Abcam Plc (LON:ABC)
Latest Headlines for Abcam Plc (LON:ABC)
|OraSure Technologies (OSUR) Names Mara Aspinall to Board|
www.streetinsider.com - June 22 at 6:32 PM
|Abcam Plc (ABC) Insider Mara G. Aspinall Buys 2,700 Shares|
www.americanbankingnews.com - June 7 at 1:26 PM
|Protein Assays Market expected to reach USD 2.41 billion in 2022|
www.prnewswire.com - June 6 at 3:19 PM
|Allscripts Healthcare Solutions (MDRX) Appoints Mara Aspinall to Director|
www.streetinsider.com - May 26 at 1:37 AM
|DIRECTOR DEALINGS: Abcam Finance Boss Gavin Wood Ups Interest|
www.morningstar.co.uk - May 3 at 3:17 PM
|Abcam Plc – Value Analysis (LONDON:ABC) : May 1, 2017|
finance.yahoo.com - May 2 at 5:28 AM
|Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : April 28, 2017|
finance.yahoo.com - April 28 at 3:05 PM
|Abcam Plc (ABC) Stock Rating Reaffirmed by Panmure Gordon|
www.americanbankingnews.com - April 20 at 7:37 PM
|Global Multiplex Assays Market Expected to Reach $5,720 Million by 2022 - Allied Market Research|
www.bizjournals.com - April 20 at 3:15 PM
|Immunohistochemistry (IHC) Market Size to Reach $3.1 Billion by 2025: Grand View Research, Inc.|
finance.yahoo.com - April 11 at 8:30 AM
|Abcam Plc (ABC) Stock Rating Reaffirmed by Stifel Nicolaus|
www.americanbankingnews.com - April 8 at 7:20 PM
|Abcam Plc : ABC-GB: Dividend Analysis : March 17th, 2017 (record date) : By the numbers : April 4, 2017|
finance.yahoo.com - April 7 at 5:22 AM
|Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : April 5, 2017|
finance.yahoo.com - April 7 at 5:22 AM
|Abcam Plc (ABC) PT Raised to GBX 864 at JPMorgan Chase & Co.|
www.americanbankingnews.com - April 1 at 5:21 PM
|Abcam Plc (ABC) PT Raised to GBX 864|
www.americanbankingnews.com - March 31 at 3:56 AM
|Abcam Plc (ABC) Receives Average Recommendation of "Hold" from Analysts|
www.americanbankingnews.com - March 29 at 1:22 PM
|Abcam Plc (ABC) Insider Alan Thomas Hirzel Purchases 6,000 Shares|
www.americanbankingnews.com - March 24 at 10:08 AM
|Abcam Plc (ABC) Earns Hold Rating from Peel Hunt|
www.americanbankingnews.com - March 23 at 4:24 AM
|Alan Thomas Hirzel Acquires 6,000 Shares of Abcam Plc (ABC) Stock|
www.americanbankingnews.com - March 21 at 7:31 AM
|Abcam Plc's (ABC) "Sell" Rating Reaffirmed at Panmure Gordon|
www.americanbankingnews.com - March 20 at 12:27 PM
|Peel Hunt Reiterates Hold Rating for Abcam Plc (ABC)|
www.americanbankingnews.com - March 18 at 12:33 AM
|This biotech stock is already worth £1.7bn — is it still a buy?|
uk.finance.yahoo.com - March 17 at 3:18 PM
|Research Analysts’ Upgrades for March, 14th (ABCZY, ADHD, AMID, CELTF, CFFN, FLXN, FSS, FURCY, GDEN, GLP)|
www.americanbankingnews.com - March 15 at 12:25 AM
|Abcam PLC (ABCZY) Lifted to “Buy” at Zacks Investment Research|
www.americanbankingnews.com - March 15 at 12:24 AM
|Peel Hunt Reaffirms Hold Rating for Abcam Plc (ABC)|
www.americanbankingnews.com - March 12 at 11:27 AM
|Abcam Plc (ABC) Receives Neutral Rating from JPMorgan Chase & Co.|
www.americanbankingnews.com - March 12 at 1:46 AM
|BRIEF-Abcam H1 pretax profit rises|
www.businessinsider.com - March 7 at 3:16 PM
|UPDATE 2-UK Stocks-Factors to watch on March 6 - Reuters|
www.reuters.com - March 6 at 10:09 AM
|Can these £1.7bn AIM growth stocks double again?|
uk.finance.yahoo.com - March 6 at 10:09 AM
|$47.08 Billion Cell Analysis Market - Global Forecast to 2023 - Research and Markets|
finance.yahoo.com - February 18 at 9:24 AM
|Octopus AIM VCT 2 plc : Final Results - Yahoo Finance - Yahoo Finance|
finance.yahoo.com - February 14 at 3:21 PM
Abcam Plc (ABC) Chart for Sunday, June, 25, 2017